期刊文献+

以不明原因发热为首发表现的恶性肿瘤69例临床分析 被引量:7

Malignancy initial presenting as fever of unknown origin
原文传递
导出
摘要 目的探讨以不明原因发热(FUO)为首发表现的恶性肿瘤患者的病因及临床特征。方法回顾性分析我院2000年1月~2007年12月间以FUO为首发表现的69例恶性肿瘤患者的病因、诊断方法和临床表现。结果69例恶性肿瘤患者男女比例为3.06:1,淋巴瘤最多见(占56.5%),肺癌次之(占24.6%)。多部位穿刺活检有助于淋巴瘤明确诊断,淋巴瘤患者PPD试验阳性率低于结核病,但差异无显著性;89.7%(35/39)的患者有血象下降改变,其中三系细胞均下降比例最高,占36.4%(14/39),83.9%(26/31)的患者乳酸脱氢酶(LDH)增高。所有肺癌患者均合并有阻塞性肺炎。结论以不明原因发热为首发表现的恶性肿瘤患者中淋巴瘤居首位,肺癌其次,仔细寻找线索有助于明确诊断。 Objective To investigate the etiopathogenisis and and clinical features of patients with malignant diseases initial presenting as fever of unknown origin (FUO). Methods The clinical datas including the cause, methods of diagnosis and clinical characters were retrospectively analyzed in patients with malignant diseases and initial presenting as FUO in Chinese PLA general hospital from January 2000 to December 2007. There were 69 cases fulfilled the criteria. Results The male-to-female ratio was 3.06: 1. Lymphoma was the most frequent ,and the second was lung cancer. Multiple biopsies was helpful for diagnosis, the positive rate of PPD test in tuberculosis was higher than in ]ymphoma, but there was no statistical significance. There were decreasing of WBC in 35/39 ( 89.7% ). Increasing lactate dehydrogen- ase (LDH) was found in 26/31 (83.9%) ;All lung cancer had obstructive pneumonia. Conclusions The first cause of malignant diseases initial presenting as FUO was lymphoma, and the second cause was lung cancer. Searching for probably clue of maligancy was helopful for diagnosis of FUO.
出处 《临床内科杂志》 CAS 2010年第5期313-315,共3页 Journal of Clinical Internal Medicine
关键词 发热 回顾性研究 肿瘤 Fever Retrospective study Malignancy
  • 相关文献

参考文献6

二级参考文献73

  • 1罗斌,王文治.萘普生诊断肿瘤性发热5例[J].中华肿瘤杂志,1996,18(6):425-425. 被引量:1
  • 2Peto J,Decarli A,La Vecchia C,et al.The European mesothclioma epidemic[J].Br J Cancer,1999,79:666. 被引量:1
  • 3Ceresoli GL,Loeati LD,Ferreri AJ,et al.Therapeutic outcome according to histologlc subtype in 121 panents with malignant pleural mesothelioma[J].Lung Cancer,2001,34:279-287. 被引量:1
  • 4Butchart EG,Ashcrofl T,Bamsley WC,et al.Pleuropneumonectomy in the management of diffuse malignant mesothelioma the pleura[J].Thorax,1976,31:15. 被引量:1
  • 5Rusch VW,Venkatraman E.The importance of surgical staging in the treatment of malignant pleural mesothdioma[J].J Thorac Cardiovase Surg,1996,111:815. 被引量:1
  • 6Leung AN,Muller NL,Miller RR.CT in differential diagnosis of diffuse pleural disease[J].AJR Am J Roentgenol,1990,154:487-492. 被引量:1
  • 7Heelan RT,Busch VW,Begg CB,et al.Staging of malignant pleund mesothelioma:comparison of CT and MR imaging[J].Am J Roentgenol,1999,172:1039-1047. 被引量:1
  • 8Duysinx B,Nguyen D,Louis R,et al.Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging[J].Chest,2004,125:489-493. 被引量:1
  • 9Zervos MD,Bizekis C,Pass HI.Malignant mesothelioma 2008[J].Curr Opin Pulm Med,2008,14:303-309. 被引量:1
  • 10Metintas M,Ozdemir N,Isiksoy S,et al.GT-guided pleural needle biopsy in the diagnosis of malignant mesothelioma[J].J Comput Assist Tomogr,1995,19:370-374. 被引量:1

共引文献28

同被引文献51

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部